Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Lava Therapeutics
Biotech
Xoma and Lava buyout cools with lower offer
Xoma and Lava are turning the temperature down, lowering the payments and closing cash conditions for an acquisition inked back in August.
Gabrielle Masson
Oct 17, 2025 2:35pm
Xoma shops for struggling biotechs, buying HilleVax and Lava
Aug 4, 2025 9:27am
Lava lays off 30% of staff to save cash
Feb 25, 2025 8:45am
Lava burnt by failure clinical-stage cancer drug in phase 1
Dec 10, 2024 9:15am
Seagen pays Lava $50M for preclinical T-cell engager for cancer
Sep 26, 2022 11:00am
Novo, Sanofi VC units lead Lava's $83M series C
Sep 17, 2020 8:25am
